Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Banks | 3 | 2007 | 4 | 0.520 |
Why?
|
| Blood Donors | 2 | 2005 | 2 | 0.460 |
Why?
|
| Blood Component Removal | 1 | 2013 | 1 | 0.400 |
Why?
|
| Citric Acid | 1 | 2013 | 1 | 0.400 |
Why?
|
| Heparin | 1 | 2013 | 8 | 0.400 |
Why?
|
| Glucose | 1 | 2013 | 50 | 0.400 |
Why?
|
| Blood Component Transfusion | 1 | 2007 | 1 | 0.260 |
Why?
|
| Quality Assurance, Health Care | 1 | 2007 | 17 | 0.260 |
Why?
|
| Blood Transfusion | 2 | 2007 | 8 | 0.240 |
Why?
|
| Laboratories, Hospital | 1 | 2005 | 2 | 0.230 |
Why?
|
| Blood Preservation | 1 | 2005 | 2 | 0.230 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2005 | 2 | 0.230 |
Why?
|
| Humans | 8 | 2015 | 6794 | 0.150 |
Why?
|
| ABO Blood-Group System | 2 | 2007 | 2 | 0.120 |
Why?
|
| Blood Grouping and Crossmatching | 2 | 2007 | 2 | 0.120 |
Why?
|
| North America | 2 | 2005 | 7 | 0.110 |
Why?
|
| Virulence Factors | 1 | 2015 | 1 | 0.110 |
Why?
|
| Drug Resistance, Multiple | 1 | 2015 | 2 | 0.110 |
Why?
|
| Data Collection | 2 | 2005 | 38 | 0.110 |
Why?
|
| Genome, Bacterial | 1 | 2015 | 4 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 18 | 0.110 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 12 | 0.110 |
Why?
|
| Acinetobacter Infections | 1 | 2015 | 6 | 0.110 |
Why?
|
| Acinetobacter baumannii | 1 | 2015 | 6 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2013 | 681 | 0.100 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 11 | 0.100 |
Why?
|
| Craniocerebral Trauma | 1 | 2013 | 10 | 0.100 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 19 | 0.100 |
Why?
|
| Blood Specimen Collection | 2 | 2007 | 5 | 0.080 |
Why?
|
| Rh-Hr Blood-Group System | 2 | 2007 | 3 | 0.070 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2007 | 1 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2007 | 7 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 31 | 0.070 |
Why?
|
| Informed Consent | 1 | 2007 | 6 | 0.070 |
Why?
|
| Elective Surgical Procedures | 1 | 2007 | 5 | 0.070 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2007 | 4 | 0.070 |
Why?
|
| Virus Diseases | 1 | 2005 | 3 | 0.060 |
Why?
|
| Blood Group Antigens | 1 | 2005 | 1 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2005 | 7 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2005 | 14 | 0.060 |
Why?
|
| Phenotype | 1 | 2005 | 91 | 0.050 |
Why?
|
| Mass Screening | 1 | 2005 | 116 | 0.050 |
Why?
|
| Chromosomes, Bacterial | 1 | 2015 | 1 | 0.030 |
Why?
|
| Genomic Islands | 1 | 2015 | 1 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2015 | 2 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2015 | 3 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2015 | 3 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 2015 | 3 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2015 | 2 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 5 | 0.030 |
Why?
|
| Genomics | 1 | 2015 | 13 | 0.030 |
Why?
|
| Middle Aged | 2 | 2013 | 2108 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 43 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 70 | 0.030 |
Why?
|
| Base Sequence | 1 | 2015 | 65 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2015 | 26 | 0.030 |
Why?
|
| Phylogeny | 1 | 2015 | 20 | 0.030 |
Why?
|
| Abbreviated Injury Scale | 1 | 2013 | 1 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2013 | 3 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2013 | 7 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2013 | 12 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 10 | 0.030 |
Why?
|
| Propensity Score | 1 | 2013 | 14 | 0.030 |
Why?
|
| Los Angeles | 1 | 2015 | 321 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2013 | 36 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2013 | 108 | 0.030 |
Why?
|
| Length of Stay | 1 | 2013 | 53 | 0.030 |
Why?
|
| Female | 2 | 2013 | 4060 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 500 | 0.020 |
Why?
|
| Adult | 1 | 2013 | 2113 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 3 | 0.020 |
Why?
|
| Rituximab | 1 | 2007 | 3 | 0.020 |
Why?
|
| Anemia | 1 | 2007 | 28 | 0.020 |
Why?
|
| Time Factors | 1 | 2007 | 321 | 0.020 |
Why?
|
| Male | 1 | 2013 | 3671 | 0.010 |
Why?
|